ArticleAsian Pacific journal of cancer prevention : APJCP2026
Clinical Significance of the S348l Mutation in BCR-ABL as a Dominant Variant in Indonesian CML Patients Under Tyrosine Kinase Inhibitor Therapy: A Cohort Study.
Tutik Harjianti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.